Alamar Biosciences, Inc. (ALMR)

Alamar Biosciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024
Cash & Equivalents	64.59	30	26.77
Short-Term Investments	-	-	52.59
Cash & Short-Term Investments	64.59	30	79.36
Cash Growth	-18.61%	-62.19%	-
Accounts Receivable	19.52	12.75	6.65
Inventory	39.93	38.48	14.41
Other Current Assets	17.43	13.47	6.28
Total Current Assets	141.47	94.71	106.7
Net Property, Plant & Equipment	36.14	36.63	35.1
Other Intangible Assets	1.84	1.99	2.04
Other Long-Term Assets	7	6.67	5.67
Total Assets	186.45	139.99	149.51
Accounts Payable	5.64	5.87	6.19
Accrued Expenses	16.81	15.76	8.49
Current Portion of Leases	1.6	2.1	1.91
Total Current Liabilities	24.05	23.73	16.59
Long-Term Debt	74.97	9.81	-
Long-Term Leases	28.98	29.56	31.19
Other Long-Term Liabilities	1.53	0.85	0.15
Total Long-Term Liabilities	105.48	40.22	31.34
Total Liabilities	129.53	63.95	47.93
Common Stock	0	0	0
Additional Paid-in Capital	12.11	9.89	5.4
Accumulated Other Comprehensive Income	-0.08	-0.07	0.15
Retained Earnings	-190.1	-168.78	-138.96
Total Common Shareholders' Equity	-178.07	-158.95	-133.41
Minority Interest	235	235	235
Shareholders' Equity	56.93	76.04	101.59
Total Liabilities & Equity	186.45	139.99	149.51
Total Debt	105.55	41.47	33.1
Net Cash (Debt)	-40.96	-11.47	46.26
Net Cash Per Share	-3.18	-0.99	3.89
Book Value	-178.07	-158.95	-133.41
Book Value Per Share	-13.83	-13.77	-11.22
Tangible Book Value	-179.91	-160.94	-135.46
Tangible Book Value Per Share	-13.98	-13.94	-11.39

Updated May 8, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q